Risultati della ricerca - Swaminathan P. Iyer

Raffina i risultati
  1. 1
    Romidepsin for the Treatment of Peripheral T-Cell Lymphoma

    Romidepsin for the Treatment of Peripheral T-Cell Lymphoma di Swaminathan P. Iyer, Francine F. Foss

    Pubblicazione 2015
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Targeting CLL-1 for acute myeloid leukemia therapy

    Targeting CLL-1 for acute myeloid leukemia therapy di Hongbing Ma, Swaminathan P. Iyer, Simrit Parmar, Yuping Gong

    Pubblicazione 2019
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    A unique aptamer-drug conjugate for targeted therapy of multiple myeloma

    A unique aptamer-drug conjugate for targeted therapy of multiple myeloma di Jia Wen, Wenjing Tao, Suyang Hao, Swaminathan P. Iyer, Youli Zu

    Pubblicazione 2015
    Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  4. 4
    Atomic force microscopy detects differences in the surface brush of normal and cancerous cells

    Atomic force microscopy detects differences in the surface brush of normal and cancerous cells di Swaminathan P. Iyer, Ravi Gaikwad, Venkatesh Subba-Rao, Craig D. Woodworth, Igor Sokolov

    Pubblicazione 2009
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study

    Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study di William G. Wierda, Swaminathan P. Iyer, Geoffrey Chan, Ira Gupta, Steen Lisby, Anders Österborg

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia

    Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia di Nianxi Zhao, Sung-Nan Pei, Jianjun Qi, Zihua Zeng, Swaminathan P. Iyer, Pei Lin, Ching‐Hsuan Tung, Youli Zu

    Pubblicazione 2015
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib

    The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib di Kevin R. Kelly, Jeffrey Ecsedy, Ernest Medina, Devalingam Mahalingam, Swaminathan P. Iyer, Steffan T. Nawrocki, Francis J. Giles, Jennifer S. Carew

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors

    Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors di Kartik Anand, Geetanjali Sahu, Ethan Burns, Allyne M. Ensor, Joe Ensor, Sai Ravi Pingali, Vivek Subbiah, Swaminathan P. Iyer

    Pubblicazione 2020
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Allogeneic Vaccination With a B7.1 HLA-A Gene-Modified Adenocarcinoma Cell Line in Patients With Advanced Non–Small-Cell Lung Cancer

    Allogeneic Vaccination With a B7.1 HLA-A Gene-Modified Adenocarcinoma Cell Line in Patients With Advanced Non–Small-Cell Lung Cancer di Luis E. Raez, Peter A. Cassileth, James J. Schlesselman, Kasi S. Sridhar, Swaminathan P. Iyer, Eva Fisher, Paulette Baldie, Eckhard R. Podack

    Pubblicazione 2004
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO‐dependent mechanism

    Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO‐dependent mechanism di Kevin R. Kelly, Steffan T. Nawrocki, Claudia M. Espitia, Mengkun Zhang, Johnny Yang, Swaminathan P. Iyer, Jeffrey Ecsedy, Francis J. Giles, Jennifer S. Carew

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

    Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells di Warren Fiskus, S. Sharma, Biren Shah, Bryce P. Portier, Santhana G.T. Devaraj, Kathy Liu, Swaminathan P. Iyer, David J. Bearss, Kapil N. Bhalla

    Pubblicazione 2014
    Testo
    Errata/Corrigenda
    Aggiungi alla lista
    Salvato in:
  12. 12
    A pilot study to evaluate home-based screening for the common non-communicable diseases by a dedicated cadre of community health workers in a rural setting in India

    A pilot study to evaluate home-based screening for the common non-communicable diseases by a dedicated cadre of community health workers in a rural setting in India di Partha Basu, Manoj Mahajan, Nilesh Patira, Sangita Prasad, Sushma Mogri, Richard Muwonge, Eric Lucas, Rengaswamy Sankaranarayanan, Swaminathan P. Iyer, Navami Naik, Kirti Jain

    Pubblicazione 2019
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors

    Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors di John Nemunaitis, Alain C. Mita, Joe Stephenson, Monica Mita, John Sarantopoulos, Swaminathan P. Iyer, Nisha Nanda, Lyon L. Gleich, Annie-Claude Benichou, Adam Craig

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells

    Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells di Warren Fiskus, S. Sharma, Saikat Saha, Biren Shah, Santhana G.T. Devaraj, Baohua Sun, Stephen Horrigan, Christopher Leveque, Youli Zu, Swaminathan P. Iyer, Kapil N. Bhalla

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    SMARCAD1 Phosphorylation and Ubiquitination Are Required for Resection during DNA Double-Strand Break Repair

    SMARCAD1 Phosphorylation and Ubiquitination Are Required for Resection during DNA Double-Strand Break Repair di Sharmistha Chakraborty, Raj K. Pandita, Shashank Hambarde, Abid R. Mattoo, Vijaya Charaka, Kazi Mokim Ahmed, Swaminathan P. Iyer, Clayton R. Hunt, Tej K. Pandita

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD

    BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD di Warren Fiskus, Sunil Sharma, Jun Qi, Bhavin Shah, Santhana G.T. Devaraj, Christopher Leveque, Bryce P. Portier, Swaminathan P. Iyer, James E. Bradner, Kapil N. Bhalla

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response

    Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response di Asher Chanan‐Khan, Kena C. Miller, David Lawrence, Swaminathan P. Iyer, Austin Miller, Francisco Hernandez‐Illatazurri, Myron S. Czuczman, Paul K. Wallace, Jerome B. Zeldis, Kelvin H. Lee

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Safety of CAR T-cell therapy in kidney transplant recipients

    Safety of CAR T-cell therapy in kidney transplant recipients di Omar Mamlouk, Ranjit Nair, Swaminathan P. Iyer, Angelina Edwards, Sattva S. Neelapu, Raphaël Steiner, Sherry Adkins, Misha Hawkins, Neeraj Saini, Kartik Devashish, Paolo Strati, Sreedhar Mandayam, Sairah Ahmed

    Pubblicazione 2020
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Ganciclovir Inhibits Lymphocyte Proliferation by Impairing DNA Synthesis

    Ganciclovir Inhibits Lymphocyte Proliferation by Impairing DNA Synthesis di Minoo Battiwalla, Yiyuan Wu, Rajinder Bajwa, Marija Radovic, Nikolaos G. Almyroudis, Brahm H. Segal, Paul K. Wallace, Ryotaro Nakamura, Swaminathan P. Iyer, Theresa Hahn, Philip L. McCarthy

    Pubblicazione 2007
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia

    Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia di Ronan Swords, Kevin R. Kelly, Peter G. Smith, James Garnsey, Devalingam Mahalingam, Ernest Medina, Kelli Oberheu, Swaminathan P. Iyer, Michael O’Dwyer, Steffan T. Nawrocki, Francis J. Giles, Jennifer S. Carew

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: